BioSpace News Archive

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company”) is pleased to announce the signing of a Share Exchange Agreement, dated May 28, 2021 (the “SEA”), pursuant to which Novo Healthnet Limited, a wholly owned subsidiary of the Company (“NHL”) will acquire Acenzia Inc.

Newly released iTero Workflow 2.0 software features include faster scanning, improved visualization, and enhanced patient communication tools that help increase practice efficiency, support better clinical diagnosis, and drive patient engagement for treatment acceptance. Available in Q3’21 on the iTero Element 5D imaging system*, a new auto-upload feature will streamline Invisalign case submissions by enabling intraoral color scan images to be used in place of traditional intraoral photos.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that as of 2021, Arena received an MSCI ESG Rating of “A.” MSCI ESG Research provides MSCI ESG Ratings on global public and a few private companies on a scale of AAA (leader) to CCC (laggard),

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, reminds stockholders that it will hold its 2021 Annual General Meeting of Stockholders on June 10, 2021 at 9:00 am ET .

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today announced that management

Atos and Huma, the digital health innovator, have announced a 5-year strategic global partnership to shift healthcare and clinical trials from hospital to home.

Consistent technological progresses in treatment administered to patients with muscular dystrophy are fueling the demand for non-hormonal steroid modulators in the market

With enhanced efficiency, fast dissolving thin films are gaining significant momentum, creating growth opportunities for oral thin films market

Afimmune, a clinical stage drug discovery company focused on the development of biologically active lipids for the treatment of cardiometabolic diseases, announced key findings with epeleuton from preclinical atherosclerosis studies.

The Government of Canada, through its COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group is supporting a new pan-Canadian study that will investigate the immune response to the COVID-19 vaccine within the South Asian community.